AI assistant
SOBR Safe, Inc. — Director's Dealing 2019
Sep 17, 2019
35413_dirs_2019-09-17_00d000b6-cb35-47c7-89b8-11dc85b45f02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransBiotec, Inc. (IMLE)
CIK: 0001425627
Period of Report: 2019-08-28
Reporting Person: Lanphere Michael A. (V.P. of Legal Affairs, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-28 | Common Stock | P | 5206430 | $0.1 | Acquired | 50144878 | Direct |
| 2019-08-28 | Common Stock | P | 21400745 | $0.0045 | Acquired | 71545623 | Direct |
Footnotes
F1: The Reporting Person acquired 5,206,430 shares of the Issuer's common stock in exchange for 520,643 shares of the Issuer's Series A Preferred Stock pursuant to the terms of a Share Exchange Agreement. The exchange was agreed to in order to assist the Issuer in complying with the closing conditions of an Asset Purchase Agreement with IDTEC, LLC.
F2: The Reporting Person acquired 21,400,745 shares of the Issuer's common stock in exchange for a $96,303.35 reduction in the amount the Issuer owes the Reporting Person under certain promissory notes. The transaction was documented with a Stock Purchase Agreement and was completed in order to assist the Issuer in complying with the closing conditions of an Asset Purchase Agreement with IDTEC, LLC.